Abstract: This invention relates to stable capsule formulations for pharmaceutical, nutraceuticals or food supplements which contain thymoquinone (THQ) as an active ingredient, and which can be stored at room temperature without significant loss of THQ during the shelf life of the capsules. The preferred capsules have a hydroxypropylmethylcellulose (HPMC) shell and may contain carvacrol as an additional active ingredient, either in synthetic form, or as part of a plant extract. Optionally, the capsules may contain a viscosity agent.

Abstract: This invention relates to a method of marketing capsule formulations for pharmaceutical, nutraceuticals or food supplements which contain oregano oil containing thymoquinone (THQ) as an active ingredient at a concentration of least 2 weight % and which can be stored at room temperature. The capsules have a hydroxypropylmethylcellulose (HPMC) shell and may contain carvacrol (CRV) as an additional active ingredient, either in synthetic form, or as part of a plant extract. Optionally, the capsules may contain a viscosity agent. The method includes the steps of advising a potential consumer of the benefits of THQ, and optionally CRV and providing a kit containing these capsules.